Sepsis is a severe infection in which the body’s immune response leads to life-threatening organ failure. bioMérieux has long been committed to the fight against sepsis.

Sepsis is a life-threatening organ dysfunction caused by an excessive immune response to a serious infection. Every year worldwide 49 million people develop sepsis, of whom 11 million do not survive. For clinicians, it is critical to diagnose the infection and define the patient’s immune profile as quickly as possible.

Sepsis - a global health crisis

The healthcare challenge

Even though it is often under-recognized, sepsis is one of the leading causes of death worldwide and one of the main infection-related causes of death. It has been recognized as a global health priority by the WHO in 2017.

Sepsis 6 infogrpahics

  • Every year across the globe, sepsis claims more lives than breast cancer, prostate cancer and HIV/AIDS combined.
  • The number of deaths from sepsis is constantly increasing, due to an aging population, invasive diagnostic techniques and the rise of antimicrobial resistance.
  • Sepsis is the most common cause of death in intensive care units.
  • It is estimated that sepsis begins outside of the hospital for nearly 80% of patients (CDC 2016). However, it is often diagnosed too late because its clinical signs and symptoms are non-specific

The role of diagnostics

  • Early recognition and rapid diagnosis are essential for early patient management; any delay in starting appropriate treatment is associated with increased mortality. Diagnostics are essential to evaluate the degree of severity of the infection, predict possible organ failure, identify the pathogen and its possible resistance profile in order to adapt the treatment.
  • Diagnostics have been clearly identified as “a major weapon” to combat this infection, according to the Global Sepsis Alliance, a non-profit organization that supports healthcare professionals in over 70 countries to improve patient outcomes. By 2020, the Global Sepsis Alliance aims for at least 60% of general and community medical centers to routinely screen for sepsis in patients with an acute infection.
  • Sepsis is often diagnosed too late because the clinical symptoms and biological signs currently used to diagnose sepsis are also seen in other conditions: fever, increased pulse, heart rate and white blood cell count.


In 2021, bioMérieux and The UK Sepsis Trust, commissioned a survey conducted in 5 European countries that demonstrates the need to accelerate awareness and education of the general population about sepsis.

Read more



Every year since 2012, bioMérieux is an official sponsor of World Sepsis Day (September 13th) organized by the Global Sepsis Alliance.

Learn more


Our solutions

To address this public health challenge, bioMérieux has adopted a solution-based approach, positioning itself as a valuable partner for healthcare professionals.

Our “Sepsis Solution” offers a complete range of solutions dedicated to caring for patients at every stage of the infection. It promotes workflow optimization and allows sepsis patients’ samples to rapidly reach the laboratory and undergo analysis.